BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossignol P, Agarwal R, Canaud B, Charney A, Chatellier G, Craig JC, Cushman WC, Gansevoort RT, Fellström B, Garza D, Guzman N, Holtkamp FA, London GM, Massy ZA, Mebazaa A, Mol PGM, Pfeffer MA, Rosenberg Y, Ruilope LM, Seltzer J, Shah AM, Shah S, Singh B, Stefánsson BV, Stockbridge N, Stough WG, Thygesen K, Walsh M, Wanner C, Warnock DG, Wilcox CS, Wittes J, Pitt B, Thompson A, Zannad F. Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints. Eur Heart J 2019;40:880-6. [PMID: 28431138 DOI: 10.1093/eurheartj/ehx209] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan MS, Bakris GL, Packer M, Shahid I, Anker SD, Fonarow GC, Wanner C, Weir MR, Zannad F, Butler J. Kidney function assessment and endpoint ascertainment in clinical trials. Eur Heart J 2021:ehab832. [PMID: 34966917 DOI: 10.1093/eurheartj/ehab832] [Reference Citation Analysis]
2 Liang HY, Hsiao YL, Yeh HC, Ting IW, Lin CC, Chiang HY, Kuo CC. Associations Between Myocardial Diastolic Dysfunction and Cardiovascular Mortality in Chronic Kidney Disease: A Large Single-Center Cohort Study. J Am Soc Echocardiogr 2021:S0894-7317(21)00866-X. [PMID: 34915133 DOI: 10.1016/j.echo.2021.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Díez J, Navarro-gonzález JF, Ortiz A, Santamaría R, de Sequera P. Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology. Nefrología (English Edition) 2021;41:391-402. [DOI: 10.1016/j.nefroe.2021.02.010] [Reference Citation Analysis]
4 Crea F. Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering. Eur Heart J 2021;42:2137-40. [PMID: 34097728 DOI: 10.1093/eurheartj/ehab295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chan K, Moe SM, Saran R, Libby P. The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart. Eur Heart J 2021;42:1244-53. [PMID: 33458768 DOI: 10.1093/eurheartj/ehaa1049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Crea F. Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation. Eur Heart J 2021;42:1185-9. [PMID: 33792670 DOI: 10.1093/eurheartj/ehab154] [Reference Citation Analysis]
7 Estruch R, Ruilope LM, Cosentino F. The year in cardiovascular medicine 2020: epidemiology and prevention. Eur Heart J 2021;42:813-21. [PMID: 33388753 DOI: 10.1093/eurheartj/ehaa1062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ishida JH, Chauhan C, Gillespie B, Gruchalla K, McCullough PA, Quella S, Romero A, Rossignol P, Wheeler DC, Malley MA, West M, Herzog CA. Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease. Clin J Am Soc Nephrol 2021;16:1435-44. [PMID: 33893163 DOI: 10.2215/CJN.17561120] [Reference Citation Analysis]
9 Díez J, Navarro-González JF, Ortiz A, Santamaría R, de Sequera P. Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology. Nefrologia 2021;41:391-402. [PMID: 33892978 DOI: 10.1016/j.nefro.2021.02.003] [Reference Citation Analysis]
10 Saleiro C, Puga L, De Campos D, Lopes J, Sousa JP, Gomes ARM, Costa M, Teixeira R, Gonçalves L. Chronic kidney disease in acute coronary syndromes: real world data of long-term outcomes. Future Cardiol 2021. [PMID: 33871286 DOI: 10.2217/fca-2020-0220] [Reference Citation Analysis]
11 Crea F. Old and new enemies: psychological stress, occupational stress, COVID-19, and a glimpse of the future. Eur Heart J 2021;42:1447-50. [PMID: 33853115 DOI: 10.1093/eurheartj/ehab193] [Reference Citation Analysis]
12 Abushouk AI, Abdelfattah OM, Hassanein M, Saad AM, Vipparla N, Isogai T, Gad MM, Nakhoul G, Krishnaswamy A, Kapadia S. Transcatheter Aortic Valve Implantation Outcomes in Chronic Kidney Disease Versus End-Stage Kidney Disease. Am J Cardiol 2021;143:165-7. [PMID: 33453172 DOI: 10.1016/j.amjcard.2021.01.002] [Reference Citation Analysis]
13 Patel RB, Ter Maaten JM, Ferreira JP, McCausland FR, Shah SJ, Rossignol P, Solomon SD, Vaduganathan M, Packer M, Thompson A, Stockbridge N, Zannad F. Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical Trials. Circulation 2021;143:949-58. [PMID: 33406882 DOI: 10.1161/CIRCULATIONAHA.120.049514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Cardone KE, Parker WM. Medication management in dialysis: Barriers and strategies. Semin Dial 2020;33:449-56. [PMID: 33210373 DOI: 10.1111/sdi.12935] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 De Luca L, Di Pasquale G, Gonzini L, Uguccioni M, Olivari Z, Casella G, Boccanelli A, De Servi S, Urbinati S, Colivicchi F, Gabrielli D, Savonitto S. Temporal Trends in Invasive Management and In-Hospital Mortality of Patients With Non-ST Elevation Acute Coronary Syndromes and Chronic Kidney Disease. Angiology 2021;72:236-43. [PMID: 33021092 DOI: 10.1177/0003319720962676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kousios A, Kouis P, Hadjivasilis A, Panayiotou A. Cardiovascular Risk Assessment Using Ultrasonographic Surrogate Markers of Atherosclerosis and Arterial Stiffness in Patients With Chronic Renal Impairment: A Narrative Review of the Evidence and a Critical View of Their Utility in Clinical Practice. Can J Kidney Health Dis 2020;7:2054358120954939. [PMID: 32963791 DOI: 10.1177/2054358120954939] [Reference Citation Analysis]
17 De Rosa R, Morici N, De Servi S, De Luca G, Galasso G, Piscione F, Ferri LA, Piatti L, Grosseto D, Tortorella G, Franco N, Lenatti L, Misuraca L, Leuzzi C, Verdoia M, Sganzerla P, Cacucci M, Ferrario M, Murena E, Sibilio G, Toso A, Savonitto S. Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention. European Heart Journal. Acute Cardiovascular Care 2020. [DOI: 10.1177/2048872620920475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Agarwal R, Rossignol P. Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial? Nephrol Dial Transplant 2020;35:728-31. [PMID: 31578572 DOI: 10.1093/ndt/gfz187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Bayes-Genis A, Bisbal F, Núñez J, Santas E, Lupón J, Rossignol P, Paulus W. Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach. J Clin Med 2020;9:E1110. [PMID: 32294958 DOI: 10.3390/jcm9041110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Georgianos PI, Agarwal R. Cardiorenal protection in advanced chronic kidney disease: research highlights from landmark papers published in Nephrology Dialysis Transplantation during 2018. Nephrol Dial Transplant 2020;35:375-8. [PMID: 31821465 DOI: 10.1093/ndt/gfz250] [Reference Citation Analysis]
21 Doyon A, Haas P, Erdem S, Ranchin B, Kassai B, Mencarelli F, Lugani F, Harambat J, Matteucci MC, Chinali M, Habbig S, Zaloszyc A, Testa S, Vidal E, Gimpel C, Azukaitis K, Kovacevic A, Querfeld U, Schaefer F. Impaired Systolic and Diastolic Left Ventricular Function in Children with Chronic Kidney Disease - Results from the 4C Study. Sci Rep 2019;9:11462. [PMID: 31391470 DOI: 10.1038/s41598-019-46653-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
22 Bayliss G. TAVR in Patients With End-Stage Renal Disease and Critical Aortic Stenosis. Journal of the American College of Cardiology 2019;73:2816-8. [DOI: 10.1016/j.jacc.2019.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Lüscher TF. Peripheral and pulmonary artery disease: an update on under-regognized cardiovascular issues. Eur Heart J 2019;40:861-4. [PMID: 33215655 DOI: 10.1093/eurheartj/ehz131] [Reference Citation Analysis]
24 Burlacu A, Genovesi S, Goldsmith D, Rossignol P, Ortiz A, Kalra PA, Małyszko J, Banach M, Kanbay M, Covic A. Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal. Pharmacol Res 2018;129:535-43. [PMID: 29208494 DOI: 10.1016/j.phrs.2017.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]